Video: Who Am I?| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: liver

U.S. Bans Another Indian Drug Plant over Production Quality

Reuters Staff  |  September 15, 2015

MUMBAI (Reuters)—The U.S. Food and Drug Administration (FDA) has banned imports from another India-based drug manufacturing plant over quality control concerns, making it the 10th site in the country this year to face such action. The FDA’s import alert on Mumbai-based Polydrug Laboratories Pvt Ltd’s Ambernath manufacturing plant comes two months after Canada banned the…

Filed under:Drug Updates Tagged with:Drug SafetyFDAFood and Drug AdministrationIndia

Rheumatologist Michelle Kahlenberg, MD, PhD, Pursues Rural Dream

Carol Patton  |  September 14, 2015

How are Annie and Abby? That’s a question some patients ask J. Michelle Kahlenberg, MD, PhD, a rheumatologist and assistant professor in the school of medicine at the University of Michigan, who also runs a lupus research lab at the University of Michigan Health System. Patients aren’t asking about her children, but family members of…

Filed under:Professional TopicsProfiles Tagged with:CareerProfilerhuematologist

New Recommendations Support Effective Use of Telemedicine in Primary Care

Will Boggs, MD  |  September 9, 2015

NEW YORK (Reuters Health)—The American College of Physicians (ACP) has issued a baker’s dozen of recommendations intended to guide the effective use of telemedicine in primary care settings. “The recommendations balance the potential benefits and expanded use of telemedicine with the importance of maintaining the patient-physician relationship and patient safety,” Hilary Daniel from American College…

Filed under:Practice SupportTechnology Tagged with:patient carePractice Managementprimary caretelemedicine

Small Grants Fund Physical Activity to Combat OA

Richard Quinn  |  September 8, 2015

To increase access to community-based physical activity for arthritis patients, the Osteoarthritis Action Alliance has awarded funding to three programs designed to implement evidence-based physical activity programs and osteoarthritis education in their communities…

Filed under:ConditionsOsteoarthritis and Bone Disorders Tagged with:Arthritis FoundationCDCcommunityCommunity-based careExerciseFundingOsteoarthritis Action Alliancephysical activity

AFIRM Act of 2015 Could Benefit Rheumatologists

Richard Quinn  |  August 28, 2015

New legislation has the potential to streamline the audit process for Medicare and Medicaid, taking a burden off small rheumatology practices…

Filed under:Legislation & AdvocacyProfessional Topics Tagged with:Centers for Medicare & Medicaid Services (CMS)

One-Year Transition Period May Ease the Pain of ICD-10

Kimberly Retzlaff  |  August 25, 2015

As the Oct. 1 deadline to transition to ICD-10 approaches, the CMS has released multiple resources, including a joint guidance statement with the AMA that details one year of claims leniency to help physicians adjust to the new coding system and smooth the transition process…

Filed under:Billing/CodingPractice Support Tagged with:Centers for Medicare & Medicaid Services (CMS)Coding & BillingICD-10

RA Diagnosis Uses Lab Tests, Clinical Insight to Rule Out Lyme

Charles Radis, DO  |  August 18, 2015

What struck me first as I walked by the exam room where Lynn P. sat was the swelling in her fingers and wrists. The bloated hands rested unnaturally on her thighs, palms up, fingers slightly flexed. Her strawberry-blond curls were offset by a high-neck, loose-fitting, burgundy sweater. Her pale skin matched her trim slacks. She had…

Filed under:ConditionsRheumatoid Arthritis Tagged with:ClinicalDiagnosislab testLyme Diseasepatient careRheumatoid arthritisrheumatologist

Heart Rate Variability to Predict Treatment Response in Patients with RA

Kathy Holliman  |  August 17, 2015

A growing understanding of the immuno­modulatory effect of the autonomic nervous system (ANS) is edging closer to having clinical applications that could one day benefit patients with rheumatoid arthritis (RA). Researchers pursuing this as an alternative path to biomarkers are investigating whether autonomic status can be used to predict response to therapy. Seattle-area rheumatologist and…

Filed under:ConditionsRheumatoid Arthritis Tagged with:autonomic nervous systempatient carepredictRheumatoid arthritisTreatment

CareFirst Sees More Than Doubled Savings on Shared Rewards with Doctors

Susan Kelly  |  July 31, 2015

(Reuters)—Insurer CareFirst BlueCross BlueShield said on Thursday its cost savings on providing healthcare rose sharply last year in a program that rewards doctors for keeping patients out of the hospital. The non-profit health insurer operates an approach to delivering care that emphasizes coordination among providers, led by a patient’s primary care physician. The model is…

Filed under:Legislation & AdvocacyProfessional Topics Tagged with:CareFirstHealth Insurance

Maintaining Board Certification Has High Hidden Cost

Will Boggs, MD  |  July 30, 2015

NEW YORK (Reuters Health)—The American Board of Internal Medicine (ABIM) maintenance-of-certification (MOC) program could cost $5.7 billion in physicians’ time and fees over the next decade, according to a new model study. “We estimate that physicians will spend 33 million hours over 10 years to fulfill MOC requirements,” Dr. Dhruv S. Kazi from the University…

Filed under:Career DevelopmentCertificationProfessional Topics Tagged with:American Board of Internal Medicine (ABIM)CertificationMaintenance of Certification

  • « Previous Page
  • 1
  • …
  • 86
  • 87
  • 88
  • 89
  • 90
  • …
  • 127
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences